APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cattle Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cattle Vaccine Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchCattle Vaccine Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Cattle Vaccine Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Cattle Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cattle Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cattle Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Cattle Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cattle Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cattle Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cattle Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cattle Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cattle Vaccine market include Merck Animal Health, Zoetis, Boehringer Ingelheim, Ceva, Jinyu Bio-Technology, CAHIC and TECON, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cattle Vaccine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cattle Vaccine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cattle Vaccine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cattle Vaccine market.

Cattle Vaccine Segment by Company

Merck Animal Health

Zoetis

Boehringer Ingelheim

Ceva

Jinyu Bio-Technology

CAHIC

TECON

Cattle Vaccine Segment by Type

Live Attenuated Vaccine

Inactivated Vaccine

Others

Cattle Vaccine Segment by Sales Channel

Government Bidding

Market Sales

Cattle Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cattle Vaccine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cattle Vaccine key companies, revenue, market share, and recent developments.

3. To split the Cattle Vaccine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cattle Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cattle Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Cattle Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cattle Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cattle Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cattle Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cattle Vaccine industry.

Chapter 3: Detailed analysis of Cattle Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cattle Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cattle Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cattle Vaccine Industry Trends Table 2. Cattle Vaccine Industry Drivers Table 3. Cattle Vaccine Industry Opportunities and Challenges Table 4. Cattle Vaccine Industry Restraints Table 5. Global Cattle Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cattle Vaccine Revenue Share by Company (2021-2026) Table 7. Global Cattle Vaccine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cattle Vaccine Key Company Manufacturing Base & Headquarters Table 9. Global Cattle Vaccine Company, Product Type & Application Table 10. Global Cattle Vaccine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cattle Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Live Attenuated Vaccine Table 15. Significant Companies of Inactivated Vaccine Table 16. Significant Companies of Others Table 17. Global Cattle Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Cattle Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Cattle Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Cattle Vaccine Sales Value Share by Type (2021-2026) Table 21. Global Cattle Vaccine Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Government Bidding Table 23. Significant Companies of Market Sales Table 24. Global Cattle Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cattle Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Cattle Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Cattle Vaccine Sales Value Share by Application (2021-2026) Table 28. Global Cattle Vaccine Sales Value Share by Application (2027-2032) Table 29. Global Cattle Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cattle Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Cattle Vaccine Sales Value Share by Region (2021-2026) Table 32. Global Cattle Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Cattle Vaccine Sales Value Share by Region (2027-2032) Table 34. Global Cattle Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cattle Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Cattle Vaccine Sales Value Market Share by Country (2021-2026) Table 37. Global Cattle Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Cattle Vaccine Sales Value Market Share by Country (2027-2032) Table 39. Merck Animal Health Company Information Table 40. Merck Animal Health Business Overview Table 41. Merck Animal Health Cattle Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Merck Animal Health Cattle Vaccine Product Portfolio Table 43. Merck Animal Health Recent Development Table 44. Zoetis Company Information Table 45. Zoetis Business Overview Table 46. Zoetis Cattle Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Zoetis Cattle Vaccine Product Portfolio Table 48. Zoetis Recent Development Table 49. Boehringer Ingelheim Company Information Table 50. Boehringer Ingelheim Business Overview Table 51. Boehringer Ingelheim Cattle Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Boehringer Ingelheim Cattle Vaccine Product Portfolio Table 53. Boehringer Ingelheim Recent Development Table 54. Ceva Company Information Table 55. Ceva Business Overview Table 56. Ceva Cattle Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Ceva Cattle Vaccine Product Portfolio Table 58. Ceva Recent Development Table 59. Jinyu Bio-Technology Company Information Table 60. Jinyu Bio-Technology Business Overview Table 61. Jinyu Bio-Technology Cattle Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Jinyu Bio-Technology Cattle Vaccine Product Portfolio Table 63. Jinyu Bio-Technology Recent Development Table 64. CAHIC Company Information Table 65. CAHIC Business Overview Table 66. CAHIC Cattle Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CAHIC Cattle Vaccine Product Portfolio Table 68. CAHIC Recent Development Table 69. TECON Company Information Table 70. TECON Business Overview Table 71. TECON Cattle Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. TECON Cattle Vaccine Product Portfolio Table 73. TECON Recent Development Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Cattle Vaccine Product Image Figure 2. Global Cattle Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cattle Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cattle Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Live Attenuated Vaccine Image Figure 8. Inactivated Vaccine Image Figure 9. Others Image Figure 10. Global Cattle Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Cattle Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Cattle Vaccine Sales Value Share by Type (2021-2032) Figure 13. Government Bidding Image Figure 14. Market Sales Image Figure 15. Global Cattle Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Cattle Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Cattle Vaccine Sales Value Share by Application (2021-2032) Figure 18. Global Cattle Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Cattle Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Cattle Vaccine Sales Value (2021-2032) & (US$ Million) Figure 21. North America Cattle Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Cattle Vaccine Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Cattle Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Cattle Vaccine Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Cattle Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Cattle Vaccine Sales Value (2021-2032) & (US$ Million) Figure 27. South America Cattle Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Cattle Vaccine Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Cattle Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Cattle Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Cattle Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Cattle Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Others
Applications
  • Government Bidding
  • Market Sales
Companies covered
  • Merck Animal Health
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • Jinyu Bio-Technology
  • CAHIC
  • TECON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cattle Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cattle Vaccine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cattle Vaccine Market Dynamics
  1. 2.1 Cattle Vaccine Industry Trends
  2. 2.2 Cattle Vaccine Industry Drivers
  3. 2.3 Cattle Vaccine Industry Opportunities and Challenges
  4. 2.4 Cattle Vaccine Industry Restraints
3 Cattle Vaccine Market by Company
  1. 3.1 Global Cattle Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Cattle Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Cattle Vaccine Company Ranking (2024-2026)
  4. 3.4 Global Cattle Vaccine Company Manufacturing Base and Headquarters
  5. 3.5 Global Cattle Vaccine Company Product Type and Application
  6. 3.6 Global Cattle Vaccine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cattle Vaccine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cattle Vaccine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cattle Vaccine Market by Type
  1. 4.1 Cattle Vaccine Type Introduction
  2. 4.1.1 Live Attenuated Vaccine
  3. 4.1.2 Inactivated Vaccine
  4. 4.1.3 Others
  5. 4.2 Global Cattle Vaccine Sales Value by Type
  6. 4.2.1 Global Cattle Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cattle Vaccine Sales Value by Type (2021-2032)
  8. 4.2.3 Global Cattle Vaccine Sales Value Share by Type (2021-2032)
5 Cattle Vaccine Market by Application
  1. 5.1 Cattle Vaccine Application Introduction
  2. 5.1.1 Government Bidding
  3. 5.1.2 Market Sales
  4. 5.2 Global Cattle Vaccine Sales Value by Application
  5. 5.2.1 Global Cattle Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cattle Vaccine Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cattle Vaccine Sales Value Share by Application (2021-2032)
6 Cattle Vaccine Regional Value Analysis
  1. 6.1 Global Cattle Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cattle Vaccine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cattle Vaccine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cattle Vaccine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cattle Vaccine Sales Value (2021-2032)
  7. 6.3.2 North America Cattle Vaccine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cattle Vaccine Sales Value (2021-2032)
  10. 6.4.2 Europe Cattle Vaccine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cattle Vaccine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cattle Vaccine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cattle Vaccine Sales Value (2021-2032)
  16. 6.6.2 South America Cattle Vaccine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cattle Vaccine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cattle Vaccine Sales Value Share by Country, 2025 VS 2032
7 Cattle Vaccine Country-level Value Analysis
  1. 7.1 Global Cattle Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cattle Vaccine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cattle Vaccine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cattle Vaccine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cattle Vaccine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cattle Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cattle Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cattle Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cattle Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cattle Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cattle Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cattle Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cattle Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cattle Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cattle Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cattle Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cattle Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cattle Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cattle Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cattle Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cattle Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cattle Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cattle Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cattle Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cattle Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cattle Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cattle Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cattle Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cattle Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cattle Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cattle Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cattle Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cattle Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cattle Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Animal Health
  2. 8.1.1 Merck Animal Health Company Information
  3. 8.1.2 Merck Animal Health Business Overview
  4. 8.1.3 Merck Animal Health Cattle Vaccine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Animal Health Cattle Vaccine Product Portfolio
  6. 8.1.5 Merck Animal Health Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Cattle Vaccine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Cattle Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Cattle Vaccine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Cattle Vaccine Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Ceva
  20. 8.4.1 Ceva Company Information
  21. 8.4.2 Ceva Business Overview
  22. 8.4.3 Ceva Cattle Vaccine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Cattle Vaccine Product Portfolio
  24. 8.4.5 Ceva Recent Developments
  25. 8.5 Jinyu Bio-Technology
  26. 8.5.1 Jinyu Bio-Technology Company Information
  27. 8.5.2 Jinyu Bio-Technology Business Overview
  28. 8.5.3 Jinyu Bio-Technology Cattle Vaccine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jinyu Bio-Technology Cattle Vaccine Product Portfolio
  30. 8.5.5 Jinyu Bio-Technology Recent Developments
  31. 8.6 CAHIC
  32. 8.6.1 CAHIC Company Information
  33. 8.6.2 CAHIC Business Overview
  34. 8.6.3 CAHIC Cattle Vaccine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CAHIC Cattle Vaccine Product Portfolio
  36. 8.6.5 CAHIC Recent Developments
  37. 8.7 TECON
  38. 8.7.1 TECON Company Information
  39. 8.7.2 TECON Business Overview
  40. 8.7.3 TECON Cattle Vaccine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 TECON Cattle Vaccine Product Portfolio
  42. 8.7.5 TECON Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst